St. Jude, firing back, posts 377 Medtronic Quattro lead deaths

April 10, 2012 by MassDevice staff

St. Jude Medical fires back against the Heart Rhythm Journal's refusal to retract a study linking its recalled Riata defibrillator leads, posting a list of 377 deaths related to arch-rival Medtronic's Quattro lead.


The editor of the Heart Rhythm Society's journal is sticking to his guns and refusing to retract an article linking some 22 deaths with St. Jude Medical's (NYSE:STJ) recalled Riata defibrillator leads, despite the med-tech giant's insistence that the study contains fundamental factual errors.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.